Abstract
Introduction

Myocardial infarction (MI) leads to cardiomyocyte loss, ventricular remodelling and consequent impairment of myocardial function. Current therapeutic approaches have limited effects in attenuating disease progression. The only successful treatment is heart transplantation. Yet it is used for late-stage patients only and constrained by the shortage of organ supply
. Recent advancements in stem cell biology, cell therapy and tissue engineering have paved the way for establishing a novel discipline in regenerative medicine. The concept of developing cell-replacement strategies has gained increasing attention [4] [5] [6] [7] . Such strategies aim to repopulate scar tissue with new contractile cells in an attempt to restore function in the failing heart. # These authors contributed equally to this work.
Two principal strategies were proposed for myocardial repairs: the cell therapy and the tissue-engineering approach. The former focuses on the direct cell transplantation into the dysfunctional myocardial areas [4] [5] [6] [7] . The latter attempts to generate a tissueengineered muscle construct followed by in vivo engraftment of the engineered tissue [8, 9] . Despite progress in the former strategy, problems such as the low rate of retention and survival still exist [10, 11] . Notwithstanding initial donor cell retention and survival following in vivo engraftment can be improved by using scaffolds, it still falls short for the injected cells to regenerate cardiac tissues to fit the shape of the infarcted area (especially when the distribution of injected cells were uneven) [12] [13] [14] [15] 16] . However, it may theoretically allow complete replacement of diseased myocardium or reconstitution of cardiac malformations to implant engineered heart tissue (EHT) [16] . In recent years, progress is made in generating EHT. Among the studies in heart tissue engineering, various sources of seeding cells were used to construct EHT, including terminal differentiated, mesenchymal stem (MSCs) and embryonic stem (ES) cells [7, 8, [16] [17] [18] . ES cells have many advantages in direct differentiation into cardiomyocytes [19] , capable of integrating with the host heart and improving electrical conduction [20, 21] 
. Therefore in theory, ES cells could potentially provide an unlimited supply of cardiomyocytes for cell therapy to regenerate functional myocardium. However, the immunological rejection after the ES cells transplantation makes the application of cell-replacement strategies difficult.
The immunological rejection in cell-replacement strategies can be avoided by using patient-specific cells derived from the induced pluripotent stem (iPS) cells [22] or the nuclear transferred embryonic stem (NT-ES) cells [23] . Although [23, 24] . In theory, the NT-ES cells carried the same genome as the donor somatic cells. After directed induction, the differentiated cells could rescue the damaged tissues without immune rejection [25] . However, the persistence of abnormalities in cloned animals has doubted whether ES cells derived by somatic cell nuclear transfer may pose risks in their therapeutic application. [26] 
NT-EB production in slow-turning lateral vessel (STLV) rotating bioreactor
Nuclear transferred embryoid body (NT-EB) in STLV was prepared by a method described previously by our laboratory [28] . In brief, the NT [18, 29] . In 
In vitro evaluation of EHTs
Myocardial infarction and EHT grafting
We generated MIs through ligation of the left coronary artery (6-0 prolene surture) in sodium pentobarbital-anesthetized (1.5%) female Sprague-Dawley rats (250 Ϯ 10 g) as described previously [15, 32] [16] . (Fig. 1C) . (Fig. 2B ) [33] . In order to investigate the cell viability in EHTs, a Live/Dead Viability/Cytotoxicity assay was performed. (Fig. 3I ). Fibroblasts were well distributed in the EHTs (Fig. 2J) . Neurons scattered throughout EHTs (Fig. 2K) . There was no positive signal in the negative control in all staining. Figure 2L showed the representative negative control image. (Fig. 3A, B (Fig. 3C, D Fig. 1 (Fig. 4A) . Immunohistochemistry staining showed the formation of cardiac muscle-like structure of the putative EHTs above the infarcted area (Fig. 4B) . The formation of blood vessel like structure in the putative EHT was observed by vWAg immunohistochemistry staining (Fig. 4C) . Whether the vessels were of donor origin or had a role in de novo vascularization remains to be investigated. The connexin43 ϩ area proved structural intercellular connections inside the putative EHTs and with the putative host native myocardium (Fig. 4D) . However, further studies are needed to evaluate whether true electrical coupling occurred. (Fig. 5B) . [34] . [28] . [29] and to construct circular engineered cardiac tissues [18] 
(for details, see the Supporting Information). Animals meeting the echocardiographic inclusion criterion (fractional shortening Ͻ40%) were used in the following experiments. Two weeks after MI, EHTs were sutured (6-0 prolene surture) onto a recipient heart (n ϭ 10). We placed the sutures in healthy myocardium adjacent to the visible infarct scars to arrange the centre of the EHTs just above the latter. The non-infarcted group (n ϭ 10) serving as sham-operation control underwent thoracotomy and cardiac exposure without coronary ligation (suturing without tying the left anterior descending coronary artery), and the untreated MI group (n ϭ 10) serving as negative control was produced by ligation of coronary without implantation of EHT. While, non-contractile grafts (NCG) were produced by formaldehyde (4%) fixation of EHT
Implantation of NCG served as tests for effects of NT-ES derived cardiomyocytes (n ϭ 8). For immunosuppression all rats received immunosuppressants (mg/kg body weight/day cyclosporin A, 5; methylprednisolone, 5) daily by subcutaneous injection.
In vivo evaluation of EHTs
Four weeks after transplantation, the suitability of EHT in heart muscle repairs after MI was evaluated by echocardiography, MEA measurement and histological examination, (for details, see the Supporting Information).
Statistical analysis
Results
Construction of the EHT
In vitro evaluation of EHTs
The results showed that the cell viability of EHTs in vitro was 92 Ϯ 4.2% (see Supporting Information [Fig. S3]). These results illustrate the survival and rearrangement of the NT-ES-derived cells in the EHTs, a prerequisite for cardiac tissue engineering.
Cell type identification in EHT
Graft effects on ventricular function
Left-ventricular systolic function (measured by fractional shortening and ejection fraction) declined significantly in infarction groups compared with that in the non-infarcted group (P Ͻ 0.01). There was a marked attenuation of the decrease in FS and EF in hearts receiving EHT versus NCG and MI controls (P Ͻ 0.01)
Macroscopy of EHT. (A) The EHTs condensed after 1 days of culture and contracted gradually. (B) Mechanical stretching of EHTs. (C) Microscopic view of spontaneously contracting EHT constructed by seeding cardiomyocytes derived from mouse NT-ES cells into liquid type I collagen. (D) The EHTs without the static stretching will contract into contact lenses-like structures in 7 days. Bars ϭ 5 mm (A, C, D), 1 cm (B). hearts was 61.7 Ϯ 2.6% versus 38.1 Ϯ 3.2% in NCG, 34.6 Ϯ 2.0% in MI rats. There was no difference in FS and EF among NCG and MI control groups at 4 weeks (P Ͼ 0.05).
Structural integration and integrity of EHT in vivo
Four weeks after grafting, the EHTs could be identified by their appearance and location. Haematoxylin and eosin stained paraffin sections showed that the putative EHT-derived tissue (diameter, 510 Ϯ 26 m) covered the infarcted myocardium above
Electrical coupling of EHT grafts to host myocardium
We assessed electrical coupling of EHTs to the host myocardium 4 weeks after engraftment by MEA. The total activation time on the region of MI, right, left and posterior segments of the investigated hearts were assessed. Sham-operated MI rats (n ϭ 6) showed the expected delay of total activation time in MI segments. In contrast, the total activation time was normal in EHT grafted hearts (n ϭ 6), indicating undelayed anterograde coupling of EHTs to the host myocardium (Fig. 5A). Acidification of the perfusion buffer to pH 6.7 led to uncoupling of EHTs from the native myocardium, proving direct but subnormal graft-host coupling
Discussion
Cardiac tissue engineering approaches are designed to repair damaged heart tissues through the assembly of cells onto biomaterial scaffolds and their implantation into the areas of lesion
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Fig. 2 Histological and immunohistochemical examination of EHTs in vitro. (A-C) Examination of EHT and natural cardiac muscle. Photomicrographs of haematoxylin-eosinstained paraffin sections from EHTs showed formation of complexes of multicellular aggregates and longitudinally oriented cell bundles (A). In comparison with mature adult rat myocardium (C), the histological morphology of the EHTs resembles that of immature neonatal cardiac tissue, especially in the high ratio of nuclei and plasma (B). (D-K) Immunohistochemical examination of EHTs. The EHTs showed immunoreactivity for a variety of cardiac markers, including the cardiac transcription factors GATA-4 and Nkx2.5, cTnT and ␣-sarcomeric actinin. GATA-4 and Nkx2.5 immunoreactivity were found in nuclei of a large number of cells in EHTs, indicating the presence of NTES-derived cardiomyocytes (D, E). The cTnT ϩ cells formed cell strands and interconnected cell bundles in most parts within the EHT patch (F). The ␣-sarcomeric actinin also expressed in the EHTs. However, the sarcomeric organization was obscure, indicating a low degree of development (G). Connexin43 (protein that expected to align following mechanical conditioning) immunostaining demonstrated the development of gap junction between the cells in EHTs (H). The vWAg ϩ cells indicated the spontaneous formation of vessel-like structures within the EHT patch (I). Fibroblasts were well distributed in the EHTs (J). Neurons scattered throughout EHTs (K). There was no positive signal in the negative control in all staining. Figure 2L showed the representative negative control image. Bars ϭ 20 m (F), 50 m (A-E, G-L).
Through this technology, functional EHTs can be manufactured to replace native ones. Despite the progress in the cardiac
In addition, the STLV-produced NT-EBs differentiated into cardiomyocytes more efficiently (Online Supporting Information). These results suggested that STLV bioreactor provided a more ideal culture condition by facilitating the formation of better quality NT-EBs. Purification of NT-ES-derived cardiomyocytes is vital in using these cells in tissue engineering or transplantation. This is because there is a mixture of non-cardiac cell types in the cells dissociated from NT-EBs. In our previous works, Percoll enrichment method proved successful in enriching cardiomyocytes from a mouse ES cell line to compare with neonatal rat cardiomyocytes © 2010 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 Echocardiographic effects of EHT graft on ventricular function. Four weeks after EHT transplantation, there was a marked attenuation of an increase in LVEDD (A) and LVESD (B) of the hearts receiving EHT versus NCG and MI controls (P Ͻ 0.01). There was a marked attenuation of the decrease in FS (C) and EF (D) in hearts receiving EHT versus NCG and MI controls (P Ͻ 0.01).
